Cytotoxic T-lymphocyte differentiation and cytogenetic alterations in gammadelta hepatosplenic T-cell lymphoma and posttransplant lymphoproliferative disorders. [electronic resource]
Producer: 19970603Description: 3490-1 p. digitalISSN:- 0006-4971
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Chromosomes, Human, Pair 7
- Cyclophosphamide
- Doxorubicin
- Humans
- Kidney Transplantation
- Liver Neoplasms -- drug therapy
- Lymphoma, T-Cell -- drug therapy
- Postoperative Complications
- Prednisolone
- Receptors, Antigen, T-Cell, alpha-beta -- genetics
- Receptors, Antigen, T-Cell, gamma-delta -- genetics
- Splenic Neoplasms -- drug therapy
- T-Lymphocyte Subsets -- immunology
- T-Lymphocytes, Cytotoxic -- immunology
- Trisomy
- Vincristine
No physical items for this record
Publication Type: Comment; Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.